We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+22.3%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$222M
Cap. Flow
-$101M
Cap. Flow %
-5.61%
Top 10 Hldgs %
44.47%
Holding
499
New
59
Increased
159
Reduced
203
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 18.96%
2 Industrials 17.26%
3 Financials 8.81%
4 Healthcare 7.81%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
251
D.R. Horton
DHI
$41.3B
$656K 0.04%
+11,829
New +$573K
SCHF icon
252
Schwab International Equity ETF
SCHF
$65.9B
$652K 0.04%
43,832
-35,024
-44% -$492K
GD icon
253
General Dynamics
GD
$105B
$640K 0.04%
4,287
-1,721
-29% -$243K
AZN icon
254
AstraZeneca
AZN
$265B
$637K 0.04%
6,013
-748
-11% -$77.3K
IJK icon
255
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.9B
$636K 0.04%
11,356
COP icon
256
ConocoPhillips
COP
$141B
$628K 0.03%
+14,944
New +$604K
EFAV icon
257
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.27B
$625K 0.03%
9,468
+731
+8% +$47.4K
EA icon
258
Electronic Arts
EA
$52.4B
$601K 0.03%
4,549
-15,449
-77% -$1.83M
KMB icon
259
Kimberly-Clark
KMB
$37B
$597K 0.03%
4,220
+2,049
+94% +$283K
PS
260
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$591K 0.03%
32,753
+16,745
+105% +$283K
PVLA
261
Palvella Therapeutics
PVLA
$2.09B
$590K 0.03%
2,379
CTSH icon
262
Cognizant
CTSH
$22.5B
$589K 0.03%
10,367
-177
-2% -$9.51K
SCHW
263
Charles Schwab
SCHW
$181B
$589K 0.03%
17,455
+4,788
+38% +$172K
GE icon
264
GE Aerospace
GE
$374B
$579K 0.03%
17,012
-673
-4% -$22.7K
SYY icon
265
Sysco
SYY
$40.3B
$567K 0.03%
+10,368
New +$545K
OXY icon
266
Occidental Petroleum
OXY
$54.9B
$564K 0.03%
+30,842
New +$486K
HRTX icon
267
Heron Therapeutics
HRTX
$87.8M
$560K 0.03%
38,038
+2,438
+7% +$40.1K
AWK icon
268
American Water Works
AWK
$26.4B
$559K 0.03%
4,350
+385
+10% +$48K
DVY icon
269
iShares Select Dividend ETF
DVY
$23.8B
$557K 0.03%
6,897
TDG icon
270
TransDigm Group
TDG
$72.1B
$553K 0.03%
1,251
+13
+1% +$4.92K
VBK icon
271
Vanguard Small-Cap Growth ETF
VBK
$23.3B
$551K 0.03%
2,761
+832
+43% +$150K
VMW
272
DELISTED
VMware, Inc
VMW
$550K 0.03%
3,549
+9
+0.3% +$1.24K
ILMN icon
273
Illumina
ILMN
$28.8B
$548K 0.03%
1,525
+26
+2% +$8.37K
BLK icon
274
Blackrock
BLK
$165B
$543K 0.03%
999
-8
-0.8% -$4.04K
CI icon
275
Cigna
CI
$77.2B
$528K 0.03%
2,816
-1,828
-39% -$347K

Similar funds

Cerity Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Cerity Partners held 499 positions worth $1.81B, up 14% from $1.59B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cerity Partners withdrew a net $101M in Q2 2020, closing 44 positions and reducing 203 holdings. Its most notable exit was Sanofi, an estimated $6.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

Against the trend, Cerity Partners opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $3.81M.

  • Cerity Partners's largest Q2 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 28,350 shares worth $3.81M.
  • Cerity Partners added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $20.8M increase.
  • Cerity Partners's biggest Q2 2020 reduction was Meta Platforms (Facebook), cutting an estimated $45.1M.
  • Cerity Partners fully exited Sanofi in Q2 2020, selling an estimated $6.3M.
  • Cerity Partners's ten largest holdings make up 44% of its $1.81B portfolio in Q2 2020.
  • Cerity Partners opened 59 new positions and closed 44 in Q2 2020.
  • Cerity Partners's portfolio value rose 14% quarter-over-quarter to $1.81B.

Based on Cerity Partners's 13F filing for Q2 2020, filed 14 Aug 2020.